But skepticism about AI’s impact on jobs, combined with perceptions about data centers’ disruptive impacts on communities, ...

David Sacks argues the viral Anthropic resignation that sparked a global AI-safety panic is not what it appears. He claims the 150-million-view ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

It would not be at all original to declare that Python is the new BASIC. Like BASIC, it has been the first programming language for a whole generation of coders, and its main advantage is that ...

IntroductionIn June 2026, Zscaler ThreatLabz identified a new malware family, tracked as SloppyRAT, that is likely leveraged by a ransomware-related threat actor. ThreatLabz observed SloppyRAT being ...

In his decades-long career in tech journalism, Dennis has written about nearly every type of hardware and software. He was a founding editor of Ziff Davis’ Computer Select in the 1990s, senior ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Anthropic CEO Dario Amodei called for a slowdown in frontier AI capability development in a September essay, warning that ...

View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.

John Schulman, Beren Millidge, and Charlie O'Neill — sat down with Dwarkesh Patel to argue about why 2036 might ...